Abano board questions Hutson’s conflict of interest in takeover bid

Mon, 16 Sep 2013

By Paul McBeth Sept. 17 (BusinessDesk) - Abano Healthcare’s board is taking advice on Peter Hutson’s ability to keep his directorship of the specialist healthcare investor while taking part in a $131.4 million takeover tilt with Australian private equity firm Archer Capital. Substantial shareholder notices today show Archer Capital, Hutson and James Reeves hold about 19.99 percent of Abano’s shares, and are locked up in a standstill arrangement for the next five months to allow the takeover attempt. Hutson’s fiduciary duties as an Abano dir...

Try free for 10 days

Trustworthy, balanced journalism every day from our growing team of New Zealand business reporters and commentators, plus more in our weekend magazine section, The Life.

Instant News Alerts based on keywords you choose or journalists you follow
Our Daily Digest of all stories at 6am, midday or 6pm
A custom library of your saved stories
An industry-leading search engine
Try for 10 days without paying and if you’re not convinced cancel with just two clicks.

Support quality New Zealand journalism by subscribing today.

Find out more

Not convinced yet?

Subscribe to our Daily News Update free newsletter.

Markets

MARKET CLOSE: Kiwi falls on economic concern

Dan Brunskill | Thu, 24 Sep 2020

The kiwi dollar sank to its lowest level since late August as the safe-haven US currency continued to attract buying amid a sustained equity sell-off due to fears of recession.

Policy

ELECTION 2020: Scared or excited about a Labour-Green govt?

Paul McBeth | Thu, 24 Sep 2020

Finance professionals have grown comfortable with Grant Robertson over the past three years. Will a new governing arrangement change that?

Law & Regulation

The FMA is running out of patience

Dan Brunskill | Thu, 24 Sep 2020

Financial services firms that keep failing compliance tests can expect to end up in court, says the FMA boss, Rob Everett.

Partner Content

The whole story behind good investment decisions

If there was ever a time when strong financial metrics were the single trademark of a good company, that time has long passed. Responsible investors need to know beyond the profit a company will generate this year or next.